How to Buy Kiniksa Pharmaceuticals International Stock
Kiniksa Pharmaceuticals International PLC
Kiniksa Pharmaceuticals, Ltd. , a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide.
Kiniksa Pharmaceuticals International stock last closed at $20.05, down 0.79% from the previous day, and has increased 17.29% in one year. It has overperformed other stocks in the Biotechnology industry by 0.95 percentage points. Kiniksa Pharmaceuticals International stock is currently +17.66% from its 52-week low of $17.04, and -28.77% from its 52-week high of $28.15.
At the moment, there are 72.64M KNSA shares outstanding. The market value of KNSA is $1.46B. In the last 24 hours, 658,722 KNSA shares were traded.
How to Buy Kiniksa Pharmaceuticals International Stock
Not sure how to invest in Kiniksa Pharmaceuticals International stock? Here's how.
- Choose where to buy Kiniksa Pharmaceuticals International stock: You need to choose an online brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you determine where to buy Kiniksa Pharmaceuticals International stock.
- Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit money your investment account: Select your payment method and add your details.
- Evaluate Kiniksa Pharmaceuticals International stock: The Kiniksa Pharmaceuticals International ticker symbol is KNSA. Is Kiniksa Pharmaceuticals International stock a good investment? Should you buy shares of KNSA? How do KNSA's underlying business fundamentals look? Do top analysts think Kiniksa Pharmaceuticals International is a good buy? Why has KNSA's stock price moved recently? (Hint: Our stock analysis website can help you understand if KNSA is a good stock to buy).
- Place your KNSA purchase: Decide if you will purchase KNSA shares at the current market price or use a limit order to buy KNSA shares at a given price.
- Keep tabs on your KNSA investment: Create a watchlist to important notifications about your position in Kiniksa Pharmaceuticals International stock.
Step 1: Choose where to buy Kiniksa Pharmaceuticals International stock
You will need a brokerage account in order to access the NASDAQ market and buy KNSA stock.
Our favorite brokerage: eToro
Based on our research, eToro is the best stock brokerage. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world markets: From Technology to Industrials, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've selected the right brokerage, you need to fill out some personal information so you are able to invest in KNSA stock today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to create your new trading account.
- Send your details by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you've filled out your info on stock market apps, you can securely and quickly fund your account:
Watch the video below to see the process of depositing money into your new brokerage account.
Step 4: Evaluate Kiniksa Pharmaceuticals International stock
After you have chosen the best place to buy Kiniksa Pharmaceuticals International stock, it's critical to analyze their stock prior to buying, so you can understand the risk as well as the opportunity.
Kiniksa Pharmaceuticals International shares quick numbers
Fundamentals of KNSA
WallStreetZen was designed to help part-time investors do better fundamental analysis quickly.
You can see all of the due diligence checks on KNSA's stock page.
Is KNSA stock undervalued?
Analysts use many financial metrics, analyses, models, and charts to gauge KNSA's intrinsic value.
Using relative valuations methods:
- KNSA could be undervalued based on its P/B ratio of 3.32x, relative to Biotechnology industry P/B ratio of 4.04x
You can access additional valuation research on KNSA's stock here.
KNSA Financial Summary
Signs that KNSA is financially healthy:
- There are more short-term assets than long-term liabilities on the KNSA balance sheet.
- There are more short-term assets than short-term liabilities on the KNSA balance sheet.
- KNSA has a low debt to equity ratio of 0.32.
- KNSA's operating cash flow of $25.69M allows it to safely service it's debt of $9.86M.
Signs that KNSA is not financially healthy:
- KNSA profit margin has gone down from 5.2% to -10.2% in the past year.
- Total KNSA debt is higher than 5 years ago, relative to shareholder equity.
- KNSA earnings of -$36.15M is not enough to cover its interest payments.
Do Wall Street analysts think it's a good time to buy KNSA stock
Out of 4 Equities analysts who give forecasts on KNSA, the consensus analyst rating on Kiniksa Pharmaceuticals International is a Strong Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are forecasting on the Kiniksa Pharmaceuticals International stock forecast page.
KNSA Trading Indicators
KNSA Growth Numbers
Last year, KNSA revenue was $423.24M. During the last three year, KNSA's revenue has gone up by 215.3% per year. This was faster than the Biotechnology industry average of 44.31%.
Dive into KNSA's earnings and revenue performance here.
Who is buying/selling KNSA?
Over the last year, executives and large shareholders at KNSA have sold more shares than they have bought.
Eben Tessari, CHIEF OPERATING OFFICER of KNSA, was the latest KNSA insider to buy. They bought $26,600.00 worth of KNSA stock on Apr 14, 2025.
Get more info about who owns KNSA shares here.
Can I get consistent income from KNSA stock?
No, Kiniksa Pharmaceuticals International doesn't provide an income stream by paying out dividends.
What do other investors have to say about KNSA?
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Place your KNSA purchase
You have two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are mostly fine. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at a specific dollar amount, place a limit order.
Click the Open Trade button and your broker will execute the order.
If you need more assistance buying stocks on eToro, watch the helpful video below:
Step 6: Keep tabs on your KNSA investment
Now that you own some KNSA shares, you'll want to keep up with your new investment.
Make a watchlist to track your KNSA stock.
KNSA Feed
How to Buy Stock in Kiniksa Pharmaceuticals International
To reiterate, here are the 6 steps to buy stock in Kiniksa Pharmaceuticals International:
- Choose where to buy Kiniksa Pharmaceuticals International stock
- Open your brokerage account
- Deposit money your investment account
- Evaluate Kiniksa Pharmaceuticals International stock
- Place your KNSA purchase
- Keep tabs on your KNSA investment
If you are looking for a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you want to monitor your investment in Kiniksa Pharmaceuticals International, create a watchlist today.
More Content You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.